Phibro Animal Health (PAHC) Earnings (2013 - 2026)
Phibro Animal Health (PAHC) earnings from Mar 31, 2013 to Mar 31, 2026. The TTM Phibro Animal Health (PAHC) earnings is $95M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Phibro Animal Health (PAHC) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +199.47% |
| 3 Years TTM | +49.33% |
| 5 Years TTM | +17.29% |
| 10 Years TTM | +3.50% |
| All Time TTM | +16.97% |
Annual Earnings change of Phibro Animal Health (PAHC)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $24M | -50.23% |
| 2025 | $48M | +1894.21% |
| 2024 | $2.42M | -92.58% |
| 2023 | $33M | -33.69% |
| 2022 | $49M | -9.58% |
| 2021 | $54M | +62.12% |
| 2020 | $34M | -38.68% |
| 2019 | $55M | -15.68% |
| 2018 | $65M | +0.42% |
| 2017 | $65M | -21.90% |
| 2016 | $83M | +37.24% |
| 2015 | $60M | -2025.88% |
| 2014 | -$3.13M | -236.09% |
| 2013 | $2.30M | -80.94% |
| 2012 | $12M | N/A |
Comparison Phibro Animal Health (PAHC) five years earnings CAGR with competitors
Phibro Animal Health (PAHC) five years earnings CAGR is 17.29%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +476.65% |
| INCR | INC Research Holdings Inc | 64.08% | +270.68% |
| TLRY | Tilray Brands Inc | 57.78% | +234.19% |
| PRGO | Perrigo Company plc | 51.08% | +195.48% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | +99.92% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | +64.17% |
| UTHR | United Therapeutics Corp | 26.00% | +50.38% |
| SBFM | Sunshine Biopharma Inc | 23.97% | +38.63% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | +25.29% |
| AYTU | Aytu BioPharma Inc | 21.24% | +22.88% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | -2.06% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -31.59% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -38.05% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -39.63% |
| ZTS | Zoetis Inc - Class A | 8.54% | -50.62% |
| KMDA | Kamada Ltd | 6.87% | -60.26% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -70.92% |
| PRFX | PRF Technologies Ltd | 4.38% | -74.66% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -78.31% |
| CPHI | China Pharma Holdings Inc | 3.58% | -79.28% |
| BHC | Bausch Health Companies Inc | 3.48% | -79.86% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -83.03% |